Recent progress:

The ChrR enzyme has been crystallized and new improved mutants were obtained by rational design.

Magnetite genes were expressed in mammalian cells.

PK/PD studies of CNOB/ChrR anticancer therapy were completed.

A new paradigm was worked out of bacterial sensitivity to antibiotics.

In collaboration with NASA (Moffett Field) a protocol was developed to test hypotheses for increased bacterial antibiotic resistance by microgavity during actual space flight on board a small satellite

 

 

a.matin@stanford.edu

 


A.C. Matin Ph.D.
Professor